1. Home
  2. KALA vs NVA Comparison

KALA vs NVA Comparison

Compare KALA & NVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • NVA
  • Stock Information
  • Founded
  • KALA 2009
  • NVA 1987
  • Country
  • KALA United States
  • NVA Australia
  • Employees
  • KALA N/A
  • NVA N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • NVA
  • Sector
  • KALA Health Care
  • NVA
  • Exchange
  • KALA Nasdaq
  • NVA NYSE
  • Market Cap
  • KALA 32.0M
  • NVA 33.3M
  • IPO Year
  • KALA 2017
  • NVA N/A
  • Fundamental
  • Price
  • KALA $6.77
  • NVA $8.13
  • Analyst Decision
  • KALA Strong Buy
  • NVA
  • Analyst Count
  • KALA 2
  • NVA 0
  • Target Price
  • KALA $16.50
  • NVA N/A
  • AVG Volume (30 Days)
  • KALA 36.4K
  • NVA 87.5K
  • Earning Date
  • KALA 11-12-2024
  • NVA 01-01-0001
  • Dividend Yield
  • KALA N/A
  • NVA N/A
  • EPS Growth
  • KALA N/A
  • NVA N/A
  • EPS
  • KALA N/A
  • NVA N/A
  • Revenue
  • KALA N/A
  • NVA N/A
  • Revenue This Year
  • KALA N/A
  • NVA N/A
  • Revenue Next Year
  • KALA N/A
  • NVA N/A
  • P/E Ratio
  • KALA N/A
  • NVA N/A
  • Revenue Growth
  • KALA N/A
  • NVA N/A
  • 52 Week Low
  • KALA $4.21
  • NVA $4.35
  • 52 Week High
  • KALA $10.97
  • NVA $12.65
  • Technical
  • Relative Strength Index (RSI)
  • KALA 53.32
  • NVA N/A
  • Support Level
  • KALA $6.65
  • NVA N/A
  • Resistance Level
  • KALA $7.85
  • NVA N/A
  • Average True Range (ATR)
  • KALA 0.36
  • NVA 0.00
  • MACD
  • KALA -0.02
  • NVA 0.00
  • Stochastic Oscillator
  • KALA 7.43
  • NVA 0.00

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About NVA NOVA MINERALS LTD SPON ADS EACH REP 60 ORD

Nova Minerals Ltd is a minerals explorer and developer focused on gold and lithium projects in North America a Gold, Antimony, focused on advancing the Estelle Project. It also includes other projects such as , Barrick's Donlin Creek Gold Project and Kinross Gold Corporation's Fort Knox Gold Mine.

Share on Social Networks: